Decreased Supplement Use For Weight Loss Possible OTC Orlistat Benefit
This article was originally published in The Tan Sheet
Executive Summary
Decreased use of dietary supplements for weight loss was perceived as a significant public health benefit by FDA advisory committee members reviewing the Rx-to-OTC switch application for GlaxoSmithKline's Alli (orlistat 60 mg)
You may also be interested in...
Alli Marketing: While Vitamins Are Friendly, Some Supplements Are Foes
Glaxo is positioning alli, with its gradual weight-loss claim and its "program, not a pill" support plan, as an FDA-approved alternative to dietary supplements
Alli Marketing: While Vitamins Are Friendly, Some Supplements Are Foes
Glaxo is positioning alli, with its gradual weight-loss claim and its "program, not a pill" support plan, as an FDA-approved alternative to dietary supplements
Alli Marketing: While Vitamins Are Friendly, Some Supplements Are Foes
Glaxo is positioning alli, with its gradual weight-loss claim and its "program, not a pill" support plan, as an FDA-approved alternative to dietary supplements